Literature DB >> 8235068

Muscle relaxant action of dantrolene sodium in rats.

S Saito1, M Harada, M Yamamoto, H Takagi, K Saito, Y Konno.   

Abstract

The relationship between the muscle relaxant action and intramuscular concentration of unchanged dantrolene sodium [1-[5-(p-natrophenyl) furfurylidene amino] hydantoin sodium hemiheptahydrate, dantrolene] by intravenous administration of dantrolene was examined in rats. The mechanism of the muscle relaxant action of dantrolene was also examined. Dantrolene, unlike tolperisone, a centrally acting muscle relaxant, dose-dependently inhibited twitch contraction evoked by electrical stimulation of both the muscle and the phrenic nerve in the rat isolated phrenic nerve-diaphragm preparation to a similar extent (IC50: 9.5 and 6.5 x 10(-6) M, respectively). Inhibition of both twitch contractions by dantrolene (50 microM) was antagonized by 4-aminopyridine (42.5 microM) and caffeine (4 mM). The twitch contraction of the gastrocnemius muscle elicited by sciatic nerve stimulation was inhibited by intravenous administration of dantrolene in a dose-dependent manner. The effective intramuscular concentration of dantrolene producing 50% depression (ID50) was 3.4 micrograms/g tissue, equal to about 1 x 10(-5) M. We thus found a close relationship between IC50 in vitro and ID50 in situ. Furthermore, this study raised the possibility that dantrolene produces its muscle relaxant action by affecting peripheral muscular Ca2+ mobilization.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8235068

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  2 in total

1.  Effect of pantoprazole and its interactions with vecuronium on the neuromuscular junction.

Authors:  Tejas K Patel; Parvati B Patel; C B Tripathi
Journal:  Indian J Pharmacol       Date:  2010-02       Impact factor: 1.200

2.  Effect of Zidovudine and its interaction with rocuronium on neuromuscular transmission.

Authors:  M J Barvaliya; T K Patel; J C Patel; C B Tripathi
Journal:  Indian J Pharm Sci       Date:  2013-03       Impact factor: 0.975

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.